advanced search

PREFILLED SYRINGES

PREFILLED SYRINGES
EXPANDING SUBCUTANEOUS DESIGN BRICK BY BRICK: THE BD NEOPAK™ GLASS PREFILLABLE SYRINGE PLATFORM
Hervé Soukiassian and Sophie Lelias discuss the established injection platforms built to achieve reliable and efficient subcutaneous delivery, going further to examine new injectable devices in development that are designed for an optimised patient experience as well as higher-volume, higher-viscosity delivery.
PREFILLED SYRINGES
ARE YOU STILL PIECING TOGETHER YOUR PREFILLABLE SYRINGE SYSTEM OR ARE YOU ALREADY FILLING IT?
Dr Bettine Boltres introduces the West Synchrony™ prefillable syringe system, explaining how the device, as a single comprehensive package, minimises regulatory complications and delays.
Testing Prefilled Syringes to ISO 11040
INJECTION
Landon Goldfarb
Instron
Testing Prefilled Syringes to ISO 11040
Instron's Landon Goldfarb talks through ISO 11040, a testing standard that addresses the design and functional properties of prefilled syringes.
BEYOND THE BARREL: PREFILLED SYRINGES THAT FOLD IN HALF
EARLY INSIGHT
Ian Speers
Pacto Medical
BEYOND THE BARREL: PREFILLED SYRINGES THAT FOLD IN HALF
Ian Speers, Robert Halvorsen and Ryan Stinebaugh discuss the unmet needs in prefilled deployability that led to the development of Slimshot™, a detached plunger rod that nests alongside the syringe, and Slimshot™ Doser, a companion concept designed to reduce the mental load of variable dosing in high-pressure delivery situations, and how these concepts can contribute to improved workflows and logistics throughout the healthcare sector.
EMPOWERING VISION FOR THE FUTURE: ADVANCED CONTAINMENT SOLUTIONS FOR OPHTHALMIC APPLICATIONS
OCULAR
Dr Linara Cornell
West Pharmaceutical Services
EMPOWERING VISION FOR THE FUTURE: ADVANCED CONTAINMENT SOLUTIONS FOR OPHTHALMIC APPLICATIONS
Dr Linara Cornell, Dr Manali Potnis and Dr Krishnendu Khan review the current landscape and challenges associated with delivery systems for ophthalmic applications, and how West Pharmaceutical Services plays a critical role in this specialised industry by providing high quality prefilled syringe components and systems that meet the stringent requirements for these sight-saving therapies.
Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta
VIDEO
Bart Burgess
SHL Medical
Cardiometabolic Treatments, Rare Diseases, Variable Dosing, and Quanta
Bart Burgess discusses some of the key areas for innovation in the industry, such as rare diseases and moving away from variable dosing solutions, and introduces Quanta – SHL's latest product offering.
Automated Testing to Decrease Time-To-Market
VIDEO
Landon Goldfarb
Instron
Automated Testing to Decrease Time-To-Market
Landon Goldfarb highlights the advantages conferred by Instron's Cobot automated testing system at both the design verification and production stages of autoinjector development.
Sustainability, Balancing Priorities, and Bringing New Solutions to Market
VIDEO
Steven Kaufman
Eco-inject
Sustainability, Balancing Priorities, and Bringing New Solutions to Market
Steven Kaufman discusses the return of sustainability to the centre of drug delivery conversation and how Eco-Inject's novel autoinjector brings fresh thinking to the sector.
TRENDS FOR 2026
EXPERT VIEW
Tom Oakley
TRENDS FOR 2026
A new reality is forming as we enter 2026 – it will not be “business as usual”. Geopolitical forces in the largest market for pharmaceuticals, the US, are likely to mean substantial changes. Here, Tom Oakley and Alex Vasiev cover those changes, the incretin juggernaut and the march of technical progress with “minitablet” dispensers, large-volume injectors and dual-chamber devices.
Interview: Enhancing Clinical Trials with CliniPilot<sup>®</sup> and Clear to Clinic™ Programme
INTERVIEW
Dr Carolina Canapè
Ypsomed
Interview: Enhancing Clinical Trials with CliniPilot® and Clear to Clinic™ Programme
Dr Carolina Canapè and Roger Lüscher talk with Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors support faster, more efficient and more effective clinical trials.
TIME TO MARKET: INCREASED CUSTOMER VALUE THROUGH GLOBAL RAMP-UP EXCELLENCE
PREFILLED SYRINGES
David Pircher
Baumann Medical
TIME TO MARKET: INCREASED CUSTOMER VALUE THROUGH GLOBAL RAMP-UP EXCELLENCE
David Pircher and Leander Moser discuss the advantages of having a global presence, which combines both local expertise and technical excellence with worldwide co-ordination of supply to deliver consistent and quality solutions.
EARLY AUTOMATION CONSIDERATIONS FOR THE DEVELOPMENT OF DRUG DELIVERY COMBINATION PRODUCTS
PREFILLED SYRINGES
Asmita Khanolkar
SMC Ltd
EARLY AUTOMATION CONSIDERATIONS FOR THE DEVELOPMENT OF DRUG DELIVERY COMBINATION PRODUCTS
Asmita Khanolkar and Al Neumann, uncover the manufacturing strategies that can be used to achieve design for automation, scale-up and sustainable solutions for clinical and commercial launch, describing the gains to be made in manufacturing efficiency when using small, automated work cells.
FRICTIONLESS ENGAGEMENT: HOW GX INMONIT™ CAN SIMPLIFY SELF-INJECTION AND STRENGTHENS PATIENT ADHERENCE
CONNECTIVITY
Giacomo Bruno
Gerresheimer
FRICTIONLESS ENGAGEMENT: HOW GX INMONIT™ CAN SIMPLIFY SELF-INJECTION AND STRENGTHENS PATIENT ADHERENCE
Dr Giacomo Bruno and Simon Buerdel consider the causes of patient non-adherence and its subsequent effects on healthcare systems, going on to present the solutions created by Gerresheimer to address the patient experience across treatment types.
TESTING AUTOINJECTORS ACCORDING TO ISO 11608-5 TO INCREASE RELIABILITY AND BOOST EFFICIENCY
PREFILLED SYRINGES
Wolfgang Moersch
ZwickRoell
TESTING AUTOINJECTORS ACCORDING TO ISO 11608-5 TO INCREASE RELIABILITY AND BOOST EFFICIENCY
Wolfgang Moersch discusses the role of automation in testing injection devices – including autoinjectors, pen injectors and on-body injectors – and how advanced testing software and robotics solutions can provide more accurate and consistent testing results.
SAFETY BY DESIGN FOR DRUG DELIVERY DEVICES
PREFILLED SYRINGES
Dr Stefan Schreiber
Scherdel Medtec
SAFETY BY DESIGN FOR DRUG DELIVERY DEVICES
Professor Stefan Schreiber, Dr Theo Wember and Sebastian Block discuss how using Design of Experiments methodology can provide insights into the manufacturing process of power springs that can enable manufacturers to more robustly control variables and produce more consistent outputs.
FROM CONCEPT TO SERIES PRODUCTION – ACCELERATING INDUSTRIALISATION IN MEDTECH
PREFILLED SYRINGES
Matthias Müller
Contexo
FROM CONCEPT TO SERIES PRODUCTION – ACCELERATING INDUSTRIALISATION IN MEDTECH
Matthias Müller and Sven Müller discuss Contexo and Probotec's combined approach to scaling drug-device combination products from laboratory prototypes to fully validated GMP commercial-scale production lines.
Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise
INTERVIEW
Dr Aurelie Rebuffet
BD (Becton Dickinson & Company)
Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise
Dr Aurélie Rebuffet and Virginie Jeymond, discuss the new requirements set out in the US Pharmacopeia (USP) Chapter <382>, including the shift towards assessing the drug-device combination product as a holistic whole and how ZebraSci and BD can support pharma companies in complying with USP <382>.
THE PLATFORM PARADOX: DEVICE DEVELOPMENT CHALLENGES WITHIN FAST EVOLVING DRUG DISCOVERY PIPELINES
EXPERT VIEW
Tim Quigg
THE PLATFORM PARADOX: DEVICE DEVELOPMENT CHALLENGES WITHIN FAST EVOLVING DRUG DISCOVERY PIPELINES
Tim Quigg, Mariam Al-Amari and Joel Gresham discuss how to enable high-dose delivery for novel biologics, using ex vivo and in silico approaches to accelerate drug-device development and improve device performance, thus de-risking projects and saving costs.
USING OXYCAPT™ MULTILAYER PLASTIC VIAL FOR GENE AND CELL THERAPIES STORED IN DRY ICE AND LIQUID NITROGEN
PREFILLED SYRINGES
Hiroki Hasegawa
Mitsubishi Gas Chemical
USING OXYCAPT™ MULTILAYER PLASTIC VIAL FOR GENE AND CELL THERAPIES STORED IN DRY ICE AND LIQUID NITROGEN
Hiroki Hasegawa and Tomohiro Suzuki consider the various challenges presented by cold-chain logistics to both traditional glass vials and many cyclo-olefin polymer alternatives, and how Mitsubishi Gas Chemical's  OXYCAPT™ vials offer significant advantages for maintaining container closure integrity compared with other materials on the market.
EVOLVING ELASTOMER STOPPER TECHNOLOGIES FOR A CHANGING REGULATORY LANDSCAPE
CGT
Dr Laure-Helene Guillemot
Aptar Pharma
EVOLVING ELASTOMER STOPPER TECHNOLOGIES FOR A CHANGING REGULATORY LANDSCAPE
Dr Laure-Hélène Guillemot and Edouard Pagnoud assess the impact of the per- and polyfluoroalkyl substances ban on elastomer stoppers and the resulting extractables and leachables challenges, highlighting how Aptar Pharma is developing new solutions to meet both regulatory expectations and customer needs.
ENHANCING DRUG DELIVERY WITH INNOVATIVE SOFT MIST INHALER TECHNOLOGY
PULMONARY
Dr Nicolas Buchmann
Resyca
ENHANCING DRUG DELIVERY WITH INNOVATIVE SOFT MIST INHALER TECHNOLOGY
Dr Nicolas Buchmann and Bernhard Müllinger, discuss the capabilities of soft mist inhalers in terms of usability for patients, sustainability, compatibility with biologics and cost-effective delivery, showcasing these advantages in Resyca’s Pre-Filled Syringe Inhaler (PFSI).
ADOPTION OF SUSTAINABILITY PRACTICES WITHIN SUBCUTANEOUS DRUG DELIVERY: INDUSTRY INSIGHTS
PHARMA VIEW
Conor O'Neill
GSK
ADOPTION OF SUSTAINABILITY PRACTICES WITHIN SUBCUTANEOUS DRUG DELIVERY: INDUSTRY INSIGHTS
Conor O’Neill (GSK), Duncan Paterson (AstraZeneca) and Dr Monica Adams (GSK) come together to discuss a recent study conducted by the Subcutaneous Drug Development & Delivery Consortium among its member organisations, digging into the pharmaceutical industry’s progress and priorities when it comes to improving the environmental impact of subcutaneous medicines.
THE COMPASS FOR INNOVATION: REGULATORY AFFAIRS AT YPSOMED
INJECTION
Stefanie Stark
Ypsomed
THE COMPASS FOR INNOVATION: REGULATORY AFFAIRS AT YPSOMED
Stefanie Stark and Sandra Schaerer-Lickova highlight how regulatory strategy enables ideas to become solutions, supports development through the product lifecycle and helps ensure that patients worldwide obtain safe and timely access.
PROVING THE DESIGN SPACE: ADVANCING THE DEVELOPMENT OF SYRINGE-DEVICE COMBINATIONS
PREFILLED SYRINGES
Enrico Barichello
Stevanato Group
PROVING THE DESIGN SPACE: ADVANCING THE DEVELOPMENT OF SYRINGE-DEVICE COMBINATIONS
Enrico Barichello and Courtney Nicholas Sutton the innovative combination of the Molly® autoinjector with Alba® and Nexa® prefilled syringes, which addresses the need to streamline device approval by establishing comprehensive compatibility testing, collaboration between suppliers and validated solutions for drug delivery.
Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation
INTERVIEW
Steven Kaufman
Portal Instruments
Interview: Steven Kaufman. Delivering the Future – Inside the World of Autoinjector Innovation
Steven Kaufman talks with ONdrugDelivery’s Guy Furness about the world of autoinjectors, looking at the current status quo in the industry, using Portal’s PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.
ALTERNATIVE APPROACH FOR DEVICE SUBSTITUTABILITY: HUMAN FACTORS STUDIES FOR GENERICS & BIOSIMILARS
PHARMA VIEW
Carrie O’Donel
Teva Pharmaceuticals
ALTERNATIVE APPROACH FOR DEVICE SUBSTITUTABILITY: HUMAN FACTORS STUDIES FOR GENERICS & BIOSIMILARS
Carrie O’Donel, Henri Akouka, Mark DeStefano along with Leslie Sanchez-Torres, discuss the shortcomings of current comparative use approaches to determining substitutability of devices for generics and biosimilars and propose an alternative approach to human factors studies based on long-standing methodologies that has the potential to unlock innovation and improve the user experience for patients.
Top